Previous 10 | Next 10 |
Summary Zynex has succumbed to extensive short selling in 2021-22 that may be in the process of reconsidering bearish bets. Projected growth rates for the company are exceptionally positive, on new product releases. Valuations are extremely low if analyst estimates prove corre...
Summary DPNCheck is a screening product sold to MA insurers which gives better member health outcomes, lower cost, and increased revenue for MA insurers. The product has consistently grown >20%. Discontinuation of Quell marketing in 2018 is masking the strong, underlying growth...
Zynex ( NASDAQ: ZYXI ) announced it had begun enrollments to test its second generation monitoring system, CM-1600, in a large-scale blood loss detection trial. The multi-site trial, first initiated with ClinCept, is designed to determine the specificity and sensitivity of the...
Zynex Monitoring Solutions Announces First Enrollment in a Blood Loss Detection Clinical Trial for its CM-1600 Monitoring System PR Newswire ENGLEWOOD, Colo. , Sept. 21, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology com...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In general, finding small-cap stocks to buy can be somewhat fraught. These are stocks with market capitalizations between roughly $300 million and $2 billion. They also tend to be riskier than large-cap names. Revenue and...
Zynex Medical to Participate in H.C. Wainwright Annual Global Investment Conference PR Newswire ENGLEWOOD, Colo. , Sept. 1, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and...
After posting the worst first half of any year since 1970 (1), the stock market has come roaring back to life in Q3, with technology and risk bets leading the way following Fed Chair Jerome Powell’s signal at the July FOMC meeting of a possible shift in policy bearing. (2) The Fed beli...
Zynex Announces First Enrollments in Apheresis Donation Clinical Trial with Second Generation Fluid Monitoring System PR Newswire ENGLEWOOD, Colo. , Aug. 15, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI), an innovative medical technology compa...
Zynex Recognized in Top 100 Healthcare Technology Companies of 2022 PR Newswire ENGLEWOOD, Colo. , Aug. 8, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-i...
Zynex Ranked in Top 50 Public Companies in Colorado PR Newswire ENGLEWOOD, Colo. , Aug. 3, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devi...
News, Short Squeeze, Breakout and More Instantly...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...